Morgan Stanley Assumes BioMarin Pharmaceutical Inc. (BMRN) at Overweight
Tweet Send to a Friend
(Updated - July 3, 2025 7:29 AM EDT)
Morgan Stanley analyst Sean Laaman assumes coverage on BioMarin Pharmaceutical Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Sean Laaman assumes coverage on BioMarin Pharmaceutical Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


